Argatroban

Results: 25



#Item
21CLINICAL REVIEW Executive Summary Section Executive Summary  I.

CLINICAL REVIEW Executive Summary Section Executive Summary I.

Add to Reading List

Source URL: www.fda.gov

Language: English
22Office of Clinical Pharmacology and Biopharmaceutics Review  NDA: [removed]SUBMISSION DATE: 29 June 2005 BRAND NAME: Argatroban Injection REVIEWER: Alfredo R. Sancho, Ph.D.

Office of Clinical Pharmacology and Biopharmaceutics Review NDA: [removed]SUBMISSION DATE: 29 June 2005 BRAND NAME: Argatroban Injection REVIEWER: Alfredo R. Sancho, Ph.D.

Add to Reading List

Source URL: www.fda.gov

Language: English
23NDA[removed]S-004 Page 4

NDA[removed]S-004 Page 4

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 16:09:28
24Prescribing Information as of October, 2004 REFLUDANĀ® [lepirudin (rDNA) for injection]

Prescribing Information as of October, 2004 REFLUDANĀ® [lepirudin (rDNA) for injection]

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:54:05
25

PDF Document

Add to Reading List

Source URL: www.anesthesia-analgesia.org

Language: English